Individuals with a dementia diagnosis before diabetes and those with macular edema were excluded, strengthening the temporal link between diabetes-related eye disease and later dementia risk. The ...

Tirzepatide also linked to fewer complications, including those requiring interventions, compared with lifestyle intervention alone.

STOCKHOLM — At the American Society of Retina Specialists (ASRS) 2024 Annual Meeting, researchers discussed how insights into potential risk factors and new treatments could improve outcomes for ...

STOCKHOLM -- The sodium glucose co-transporter 2 (SGLT2) class of diabetes medications may offer more protection against diabetic retinopathy as compared with other hypoglycemic agents, an analysis of ...

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of ...

Please provide your email address to receive an email when new articles are posted on . APX3330 is an oral, small-molecule Ref-1 inhibitor being developed for treating diabetic retinopathy. It reduced ...

For patients with type 2 diabetes mellitus, most eyes have no worsening of diabetic retinopathy (DR) after initiation of semaglutide, according to a study presented at the annual meeting of the ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

Breye Therapeutics ApS (Breye), a clinical-stage ophthalmology-focused biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announces clinical data ...

Breye is advancing danegaptide to Phase II trials after the drug showed signs of improving disease activity in a Phase Ib ...